SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 316 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,992,000 | +21.6% | 158,677 | +0.8% | 0.02% | -45.5% |
| Q3 2020 | $3,282,000 | +1.1% | 157,477 | +15.2% | 0.04% | +76.0% |
| Q2 2020 | $3,247,000 | -99.9% | 136,735 | -2.7% | 0.02% | 0.0% |
| Q1 2020 | $2,528,000,000 | -30.9% | 140,535 | -8.8% | 0.02% | +4.2% |
| Q4 2019 | $3,656,000,000 | +39039.3% | 154,135 | -54.7% | 0.02% | -63.1% |
| Q3 2019 | $9,341,000 | -33.8% | 339,910 | -20.2% | 0.06% | -33.0% |
| Q2 2019 | $14,103,000 | -28.4% | 426,210 | -24.2% | 0.10% | -30.2% |
| Q1 2019 | $19,705,000 | -4.7% | 562,360 | -9.7% | 0.14% | -20.6% |
| Q4 2018 | $20,678,000 | +5.5% | 622,460 | +59.9% | 0.18% | +24.1% |
| Q3 2018 | $19,603,000 | -25.1% | 389,335 | -11.0% | 0.14% | -31.6% |
| Q2 2018 | $26,184,000 | +237.4% | 437,500 | +158.2% | 0.21% | +243.3% |
| Q1 2018 | $7,761,000 | – | 169,475 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |